JENKEM(SH:688356) Ge Long Hui A P P·2025-08-28 08:52Core Insights - The company reported a revenue of 130 million yuan for the first half of 2025, representing a year-on-year growth of 0.89% [1] - The net profit attributable to shareholders decreased by 21.08% to 22.05 million yuan, while the net profit excluding non-recurring gains and losses fell by 21.50% to 17.05 million yuan [1] - Basic earnings per share stood at 0.36 yuan [1] Revenue Breakdown - Main business revenue remained stable with a slight increase of 0.89% compared to the same period last year [1] - Product sales revenue was 125.56 million yuan, showing a decline of 0.26% year-on-year, while technical service revenue increased by 83.77% to 3.78 million yuan [1] - Domestic sales revenue dropped significantly by 58.35% to 20.48 million yuan due to a major client reducing orders after building its own production capacity, alongside fluctuations in orders from clients in new drug and medical device development [1] - Export sales revenue rose by 36.96% to 105.08 million yuan, driven by a rapid increase in orders from international pharmaceutical clients for commercialized products [1]